These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31767511)

  • 1. Assessment of adherence to oral antipsychotic medications: What has changed over the past decade?
    Velligan DI; Maples NJ; Pokorny JJ; Wright C
    Schizophr Res; 2020 Jan; 215():17-24. PubMed ID: 31767511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining and assessing adherence to oral antipsychotics: a review of the literature.
    Velligan DI; Lam YW; Glahn DC; Barrett JA; Maples NJ; Ereshefsky L; Miller AL
    Schizophr Bull; 2006 Oct; 32(4):724-42. PubMed ID: 16707778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia--a review of the past decade.
    Barkhof E; Meijer CJ; de Sonneville LM; Linszen DH; de Haan L
    Eur Psychiatry; 2012 Jan; 27(1):9-18. PubMed ID: 21561742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological considerations in estimating adherence and persistence for a long-acting injectable medication.
    Campagna EJ; Muser E; Parks J; Morrato EH
    J Manag Care Spec Pharm; 2014 Jul; 20(7):756-66. PubMed ID: 24967528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
    J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to Oral Antipsychotics Measured by Electronic Adherence Monitoring in Schizophrenia: A Systematic Review and Meta-analysis.
    Yaegashi H; Kirino S; Remington G; Misawa F; Takeuchi H
    CNS Drugs; 2020 Jun; 34(6):579-598. PubMed ID: 32219681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring Medication Adherence in Patients With Schizophrenia: An Integrative Review.
    Bright CE
    Arch Psychiatr Nurs; 2017 Feb; 31(1):99-110. PubMed ID: 28104068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence self-report instruments: implications for practice and research.
    Rolley JX; Davidson PM; Dennison CR; Ong A; Everett B; Salamonson Y
    J Cardiovasc Nurs; 2008; 23(6):497-505. PubMed ID: 18953213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia.
    Boardman G; McCann T; Kerr D
    J Adv Nurs; 2014 Oct; 70(10):2293-302. PubMed ID: 24628395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships among subjective and objective measures of adherence to oral antipsychotic medications.
    Velligan DI; Wang M; Diamond P; Glahn DC; Castillo D; Bendle S; Lam YW; Ereshefsky L; Miller AL
    Psychiatr Serv; 2007 Sep; 58(9):1187-92. PubMed ID: 17766564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.
    Sun SX; Liu GG; Christensen DB; Fu AZ
    Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peers experience of delivering a problem-solving programme to enhance antipsychotic medication adherence for individuals with schizophrenia.
    Boardman G; Kerr D; McCann T
    J Psychiatr Ment Health Nurs; 2015 Aug; 22(6):423-30. PubMed ID: 25944402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
    Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia.
    Sapra M; Vahia IV; Reyes PN; Ramirez P; Cohen CI
    Schizophr Res; 2008 Dec; 106(2-3):348-55. PubMed ID: 18851906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data.
    Yan T; Greene M; Chang E; Hartry A; Touya M; Broder MS
    Adv Ther; 2018 Oct; 35(10):1612-1625. PubMed ID: 30206822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of measures of medication adherence in consumers with unipolar depression.
    Srimongkon P; Aslani P; Chen TF
    Res Social Adm Pharm; 2019 Jan; 15(1):3-22. PubMed ID: 29526664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should antipsychotic medications for schizophrenia be given for a lifetime? Replication of a naturalistic, long-term, follow-up study of antipsychotic treatment.
    Glick ID; Zamora D; Kamis D; Davis JM
    CNS Spectr; 2019 Oct; 24(5):557-563. PubMed ID: 30777584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring adherence to antipsychotic medications for schizophrenia: Concordance and validity among a community sample in rural China.
    Xu DR; Gong W; Gloyd S; Caine ED; Simoni J; Hughes JP; Xiao S; He W; Dai B; Lin M; Nie J; He H
    Schizophr Res; 2018 Nov; 201():307-314. PubMed ID: 29807806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
    Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
    Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.